[go: up one dir, main page]

WO2002020747A3 - Regulation of human tyrosine phosphatase-like enzyme - Google Patents

Regulation of human tyrosine phosphatase-like enzyme Download PDF

Info

Publication number
WO2002020747A3
WO2002020747A3 PCT/EP2001/010205 EP0110205W WO0220747A3 WO 2002020747 A3 WO2002020747 A3 WO 2002020747A3 EP 0110205 W EP0110205 W EP 0110205W WO 0220747 A3 WO0220747 A3 WO 0220747A3
Authority
WO
WIPO (PCT)
Prior art keywords
enzyme
tyrosine phosphatase
human tyrosine
regulation
reagents
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/EP2001/010205
Other languages
French (fr)
Other versions
WO2002020747A2 (en
Inventor
Sophia Kossida
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG filed Critical Bayer AG
Priority to AU2001291824A priority Critical patent/AU2001291824A1/en
Publication of WO2002020747A2 publication Critical patent/WO2002020747A2/en
Publication of WO2002020747A3 publication Critical patent/WO2002020747A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/136—Screening for pharmacological compounds
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/16—Primer sets for multiplex assays
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/04—Screening involving studying the effect of compounds C directly on molecule A (e.g. C are potential ligands for a receptor A, or potential substrates for an enzyme A)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Reagents which regulate human tyrosine phosphatase-like enzyme and reagents which bind to human tyrosine phosphatase-like enzyme gene products can play a role in preventing, ameliorating, or correcting dysfunctions or diseases including, but not limited to, obesity, diabetes, CNS disorders, chronic obstructive pulmonary disease, cardiovascular diseases, and cancer.
PCT/EP2001/010205 2000-09-11 2001-09-05 Regulation of human tyrosine phosphatase-like enzyme Ceased WO2002020747A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2001291824A AU2001291824A1 (en) 2000-09-11 2001-09-05 Regulation of human tyrosine phosphatase-like enzyme

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US23156800P 2000-09-11 2000-09-11
US60/231,568 2000-09-11
US25140300P 2000-12-06 2000-12-06
US60/251,403 2000-12-06

Publications (2)

Publication Number Publication Date
WO2002020747A2 WO2002020747A2 (en) 2002-03-14
WO2002020747A3 true WO2002020747A3 (en) 2003-02-13

Family

ID=26925223

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2001/010205 Ceased WO2002020747A2 (en) 2000-09-11 2001-09-05 Regulation of human tyrosine phosphatase-like enzyme

Country Status (2)

Country Link
AU (1) AU2001291824A1 (en)
WO (1) WO2002020747A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7153678B2 (en) 2000-12-20 2006-12-26 Bristol-Myers Squibb Polynucleotides encoding the novel human phosphatase, RET31, and variants thereof

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001009345A1 (en) * 1999-07-29 2001-02-08 Helix Research Institute Novel genes encoding protein kinase/protein phosphatase
WO2001009316A1 (en) * 1999-07-29 2001-02-08 Helix Research Institute Novel genes encoding protein kinase/protein phosphatase
WO2001012819A2 (en) * 1999-08-13 2001-02-22 Sugen, Inc. Protein phosphatases and diagnosis and treatment of phosphatase-related disorders
WO2002057460A2 (en) * 2000-12-20 2002-07-25 Bristol-Myers Squibb Company Polynucleotides encoding human phosphatases

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001009345A1 (en) * 1999-07-29 2001-02-08 Helix Research Institute Novel genes encoding protein kinase/protein phosphatase
WO2001009316A1 (en) * 1999-07-29 2001-02-08 Helix Research Institute Novel genes encoding protein kinase/protein phosphatase
WO2001012819A2 (en) * 1999-08-13 2001-02-22 Sugen, Inc. Protein phosphatases and diagnosis and treatment of phosphatase-related disorders
WO2002057460A2 (en) * 2000-12-20 2002-07-25 Bristol-Myers Squibb Company Polynucleotides encoding human phosphatases

Non-Patent Citations (9)

* Cited by examiner, † Cited by third party
Title
DATABASE EMBL [online] 1 May 1997 (1997-05-01), XP002211892, retrieved from EBI Database accession no. P91585 *
DATABASE EMBL [online] 1 October 2000 (2000-10-01), WATANABE K ET AL.: "Hypothetical protein FLJ20442", XP002211926, retrieved from EBI Database accession no. Q9NX48 *
DATABASE EMBL [online] 16 August 2002 (2002-08-16), "Sequence 5 from Patent WO02057460", XP002211894, retrieved from EBI Database accession no. AX482336 *
DATABASE EMBL [online] 22 February 2000 (2000-02-22), "Homo sapiens cDNA FLJ20442 fis, clone KAT04828", XP002211889, retrieved from EBI Database accession no. AK000449 *
DATABASE EMBL [online] 26 November 2001 (2001-11-26), OTA T ET AL.: "Amino acid sequence of a human protein", XP002211927, retrieved from EBI Database accession no. AAG67634 *
DATABASE EMBL [online] 26 November 2001 (2001-11-26), OTA T. ET AL.: "Amino acid sequence of a human polypeptide", XP002211925, retrieved from EBI Database accession no. AAG67455 *
DATABASE EMBL [online] XP002211893, retrieved from EBI Database accession no. AX086043 *
DATABASE EMBL [online] XP002211944, retrieved from EBI Database accession no. AX086042 *
FAUMAN E B ET AL: "Structure and function of the protein tyrosine phosphatases", TIBS TRENDS IN BIOCHEMICAL SCIENCES, ELSEVIER PUBLICATION, CAMBRIDGE, EN, vol. 21, no. 11, 1 November 1996 (1996-11-01), pages 413 - 417, XP004071016, ISSN: 0968-0004 *

Also Published As

Publication number Publication date
AU2001291824A1 (en) 2002-03-22
WO2002020747A2 (en) 2002-03-14

Similar Documents

Publication Publication Date Title
WO2002006453A3 (en) Regulation of human desc1-like serine protease
WO2002042435A3 (en) Regulation of human tyrosine phosphatase
WO2002020747A3 (en) Regulation of human tyrosine phosphatase-like enzyme
WO2002031160A3 (en) Regulation of human phospholipase a2-like enzyme
WO2002036629A3 (en) Regulation of human serotonin receptor precursor
WO2002031161A3 (en) Regulation of human phospholipase-like enzyme
WO2004031375A3 (en) Regulation of human 3’, 5’ cyclic nucleotide phosphodiesterase pde1c
WO2002010403A3 (en) Regulation of human phosphatidylinositol-specific phospholipase c-like enzyme
WO2002031162A3 (en) Regulation of human phospholipase a2-like enzyme
WO2002020732A3 (en) Regulation of human map kinase phosphatase-like enzyme
WO2001077149A3 (en) Regulation of human cyslt2-like gpcr protein
WO2002031125A3 (en) Human phospholipase a2-like enzyme
WO2002032938A3 (en) Regulation of human pgc-1-like protein
WO2002026996A3 (en) Regulation of human phosphatidylinositol-specific phospholipase c-like enzyme
WO2003052088A3 (en) Regulation of human sialyltransferase
WO2002062974A3 (en) Regulation of human elongase hselo1-like protein
WO2002000704A3 (en) Regulation of human phospholipase c-like enzyme
WO2002000855A3 (en) Regulation of human s-acyl fatty acid synthase thioesterase-like enzyme
WO2002036613A3 (en) Regulation of human patched-like protein
WO2002033056A3 (en) Regulation of human serine-threonine protein kinase
WO2002062975A3 (en) Regulation of human elongase hselo1-like protein
WO2002033080A3 (en) Regulation of human netrin binding membrane receptor unc5h-1
WO2002046403A3 (en) Regulation of human patched-like protein
WO2002055710A3 (en) Regulation of human purple acid phosphatase
WO2002006455A3 (en) Regulation of human airway trypsin protease-like enzyme

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PH PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP